← Back
Data updated: Mar 10, 2026
DASH PHARMS NATCO
CardiovascularOncology
DASH PHARMS NATCO is a generic drug manufacturer focused on Cardiovascular, Oncology.
1991
Since
3
Drugs
-
Trials
7
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Oncology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (0)
Company Info
- First Approval
- 1991-01-17
- Latest
- 2017-11-20
- Applications
- 3